Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Rationale and design of the Study to Understand Fall Reduction and vitamin D in You (STURDY): A randomized clinical trial of vitamin D supplement doses for the prevention of falls in older adults.

Michos ED, Mitchell CM, Miller ER 3rd, Sternberg AL, Juraschek SP, Schrack JA, Szanton SL, Walston JD, Kalyani RR, Plante TB, Christenson RH, Shade D, Tonascia J, Roth DL, Appel LJ; STURDY Collaborative Research Group, Appel LJ, Cronin N, Juraschek SP, McClure S, Mitchell CM, Plante TB, Kalyani RR, Roth DL, Schrack JA, Szanton SL, Urbanek J, Walston J, Baksh S, Blackford AL, Chattopadhyay S, Dodge J, Ewing C, Jackson R, Lears A, Meinert C, Shade D, Smith M, Sternberg AL, Tonascia J, Van Natta ML, Wagoner A, Michos ED, Bowers P, Coresh J, Crunkleton T, Dick B, Evans R, Godwin M, Hammann L, Hawks D, Horning K, Minotti M, Myers M, Raley L, Reid C, Spikes A, Stouffer R, Weicht K, Miller ER 3rd, Carey B, Charleston J, DeRoche-Brown N, Gayles D, Glenn-Smith I, Johnson D, Johnson M, Keyes E, McArthur K, Santiago D, Sapun C, Sneed V, Thomas L, Christenson RH, Duh SH, Rebuck H, Rosen C, Cook T, Duncan P, Hansen K, Kenny A, Shapses S, Hannah J, Romashkan S, Davis CD, Guralnik JM, Gallagher JC.

Contemp Clin Trials. 2018 Aug 20. pii: S1551-7144(18)30316-1. doi: 10.1016/j.cct.2018.08.004. [Epub ahead of print]

PMID:
30138718
2.

Comparison of Frequency of Atherosclerotic Cardiovascular and Safety Events With Systolic Blood Pressure <120 mm Hg Versus 135-139 mm Hg in a Systolic Blood Pressure Intervention Trial Primary Prevention Subgroup.

Plante TB, Juraschek SP, Miller ER 3rd, Appel LJ, Cushman M, Littenberg B.

Am J Cardiol. 2018 Jul 4. pii: S0002-9149(18)31333-X. doi: 10.1016/j.amjcard.2018.06.041. [Epub ahead of print]

PMID:
30115425
3.

Design Features of Randomized Clinical Trials of Vitamin D and Falls: A Systematic Review.

Tang O, Juraschek SP, Appel LJ.

Nutrients. 2018 Jul 26;10(8). pii: E964. doi: 10.3390/nu10080964. Review.

4.

Association of orthostatic hypotension with incident dementia, stroke, and cognitive decline.

Rawlings AM, Juraschek SP, Heiss G, Hughes T, Meyer ML, Selvin E, Sharrett AR, Windham BG, Gottesman RF.

Neurology. 2018 Aug 21;91(8):e759-e768. doi: 10.1212/WNL.0000000000006027. Epub 2018 Jul 25.

PMID:
30045960
5.

Orthostatic Hypotension and Risk of Clinical and Subclinical Cardiovascular Disease in Middle-Aged Adults.

Juraschek SP, Daya N, Appel LJ, Miller ER 3rd, McEvoy JW, Matsushita K, Ballantyne CM, Selvin E.

J Am Heart Assoc. 2018 May 7;7(10). pii: e008884. doi: 10.1161/JAHA.118.008884.

6.

Reply: The Role of Salt Reduction in the Management of Hypertension.

Juraschek SP, Miller ER 3rd, Appel LJ.

J Am Coll Cardiol. 2018 Apr 10;71(14):1598-1599. doi: 10.1016/j.jacc.2018.02.012. No abstract available.

PMID:
29622171
7.

Late life socioeconomic status and hypertension in an aging cohort: the Atherosclerosis Risk in Communities Study.

McDoom MM, Palta P, Vart P, Juraschek SP, Kucharska-Newton A, Diez Roux AV, Coresh J.

J Hypertens. 2018 Jun;36(6):1382-1390. doi: 10.1097/HJH.0000000000001696.

PMID:
29621068
8.

Orthostatic Hypotension and Symptoms in the AASK Trial.

Juraschek SP, Miller ER 3rd, Appel LJ.

Am J Hypertens. 2018 May 7;31(6):665-671. doi: 10.1093/ajh/hpy010.

PMID:
29370333
9.

Use of online recruitment strategies in a randomized trial of cancer survivors.

Juraschek SP, Plante TB, Charleston J, Miller ER, Yeh HC, Appel LJ, Jerome GJ, Gayles D, Durkin N, White K, Dalcin A, Hermosilla M.

Clin Trials. 2018 Apr;15(2):130-138. doi: 10.1177/1740774517745829. Epub 2018 Jan 24.

PMID:
29361843
10.

Predictors of Insulin Initiation in Patients with Type 2 Diabetes: An Analysis of the Look AHEAD Randomized Trial.

Pilla SJ, Yeh HC, Juraschek SP, Clark JM, Maruthur NM.

J Gen Intern Med. 2018 Jun;33(6):839-846. doi: 10.1007/s11606-017-4282-9. Epub 2018 Jan 19.

PMID:
29352421
11.

Effects of a Dietary Approach to Stop Hypertension (DASH) Diet Intervention on Serum Uric Acid in African Americans With Hypertension.

Juraschek SP, White K, Tang O, Yeh HC, Cooper LA, Miller ER 3rd.

Arthritis Care Res (Hoboken). 2018 Jan 17. doi: 10.1002/acr.23515. [Epub ahead of print]

PMID:
29342506
12.

Effects of Sodium Reduction and the DASH Diet in Relation to Baseline Blood Pressure.

Juraschek SP, Miller ER 3rd, Weaver CM, Appel LJ.

J Am Coll Cardiol. 2017 Dec 12;70(23):2841-2848. doi: 10.1016/j.jacc.2017.10.011. Epub 2017 Nov 12.

PMID:
29141784
13.

Chronic kidney disease: Intensive blood pressure reduction lowers mortality in CKD.

Juraschek SP, Appel LJ.

Nat Rev Nephrol. 2018 Jan;14(1):5-6. doi: 10.1038/nrneph.2017.154. Epub 2017 Nov 7. No abstract available.

14.

Time Course of Change in Blood Pressure From Sodium Reduction and the DASH Diet.

Juraschek SP, Woodward M, Sacks FM, Carey VJ, Miller ER 3rd, Appel LJ.

Hypertension. 2017 Nov;70(5):923-929. doi: 10.1161/HYPERTENSIONAHA.117.10017.

PMID:
28993451
15.

Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension.

Juraschek SP, Appel LJ, Miller ER 3rd.

Am J Hypertens. 2017 Sep 1;30(9):871-875. doi: 10.1093/ajh/hpx113.

16.

Association of History of Dizziness and Long-term Adverse Outcomes With Early vs Later Orthostatic Hypotension Assessment Times in Middle-aged Adults.

Juraschek SP, Daya N, Rawlings AM, Appel LJ, Miller ER 3rd, Windham BG, Griswold ME, Heiss G, Selvin E.

JAMA Intern Med. 2017 Sep 1;177(9):1316-1323. doi: 10.1001/jamainternmed.2017.2937.

17.

Relation of Exercise Capacity to Risk of Development of Diabetes in Patients on Statin Therapy (the Henry Ford Exercise Testing Project).

Shaya GE, Juraschek SP, Feldman DI, Brawner CA, Ehrman JK, Keteyian SJ, Al-Mallah MH, Blaha MJ.

Am J Cardiol. 2017 Sep 1;120(5):769-773. doi: 10.1016/j.amjcard.2017.05.048. Epub 2017 Jun 15.

PMID:
28716336
18.

Effects of dietary carbohydrate on 1,5-anhydroglucitol in a population without diabetes: results from the OmniCarb trial.

Juraschek SP, Miller ER 3rd, Appel LJ, Christenson RH, Sacks FM, Selvin E.

Diabet Med. 2017 Oct;34(10):1407-1413. doi: 10.1111/dme.13391. Epub 2017 Jul 9.

19.

DASH diet and change in serum uric acid over time.

Tang O, Miller ER 3rd, Gelber AC, Choi HK, Appel LJ, Juraschek SP.

Clin Rheumatol. 2017 Jun;36(6):1413-1417. doi: 10.1007/s10067-017-3613-x. Epub 2017 Mar 31.

20.

Pilot study of the effect of cholecalciferol supplementation on hepcidin in children with chronic kidney disease: Results of the D-fense Trial.

Atkinson MA, Juraschek SP, Bertenthal MS, Detrick B, Furth SL, Miller ER 3rd.

Pediatr Nephrol. 2017 May;32(5):859-868. doi: 10.1007/s00467-016-3563-6. Epub 2016 Dec 24.

21.

Opposing effects of sodium intake on uric acid and blood pressure and their causal implication.

Juraschek SP, Choi HK, Tang O, Appel LJ, Miller ER 3rd.

J Am Soc Hypertens. 2016 Dec;10(12):939-946.e2. doi: 10.1016/j.jash.2016.10.012. Epub 2016 Nov 11.

22.

Effect of type and amount of dietary carbohydrate on biomarkers of glucose homeostasis and C reactive protein in overweight or obese adults: results from the OmniCarb trial.

Juraschek SP, Miller ER 3rd, Selvin E, Carey VJ, Appel LJ, Christenson RH, Sacks FM.

BMJ Open Diabetes Res Care. 2016 Nov 14;4(1):e000276. eCollection 2016.

23.

Phosphorus Additives and Albuminuria in Early Stages of CKD: A Randomized Controlled Trial.

Chang AR, Miller ER 3rd, Anderson CA, Juraschek SP, Moser M, White K, Henry B, Krekel C, Oh S, Charleston J, Appel LJ.

Am J Kidney Dis. 2017 Feb;69(2):200-209. doi: 10.1053/j.ajkd.2016.08.029. Epub 2016 Nov 16.

24.

Orthostatic Hypotension in Middle-Age and Risk of Falls.

Juraschek SP, Daya N, Appel LJ, Miller ER 3rd, Windham BG, Pompeii L, Griswold ME, Kucharska-Newton A, Selvin E.

Am J Hypertens. 2017 Feb;30(2):188-195. doi: 10.1093/ajh/hpw108. Epub 2016 Sep 16.

25.

Effects of the Dietary Approaches to Stop Hypertension (DASH) Diet and Sodium Intake on Serum Uric Acid.

Juraschek SP, Gelber AC, Choi HK, Appel LJ, Miller ER 3rd.

Arthritis Rheumatol. 2016 Dec;68(12):3002-3009. doi: 10.1002/art.39813.

26.

Effect of glycemic index and carbohydrate intake on kidney function in healthy adults.

Juraschek SP, Chang AR, Appel LJ, Anderson CA, Crews DC, Thomas L, Charleston J, Miller ER 3rd.

BMC Nephrol. 2016 Jul 8;17(1):70. doi: 10.1186/s12882-016-0288-5.

27.

The association of clinical indication for exercise stress testing with all-cause mortality: the FIT Project.

Kim J, Al-Mallah M, Juraschek SP, Brawner C, Keteyian SJ, Nasir K, Dardari ZA, Blumenthal RS, Blaha MJ.

Arch Med Sci. 2016 Apr 1;12(2):303-9. doi: 10.5114/aoms.2016.59255. Epub 2016 Apr 12.

28.

Sex Differences in Cardiorespiratory Fitness and All-Cause Mortality: The Henry Ford ExercIse Testing (FIT) Project.

Al-Mallah MH, Juraschek SP, Whelton S, Dardari ZA, Ehrman JK, Michos ED, Blumenthal RS, Nasir K, Qureshi WT, Brawner CA, Keteyian SJ, Blaha MJ.

Mayo Clin Proc. 2016 Jun;91(6):755-62. doi: 10.1016/j.mayocp.2016.04.002. Epub 2016 May 6.

29.

Response to Letter Regarding Article, "Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation: Results From the Henry Ford Exercise Testing (FIT) Project".

Qureshi WT, Alirhayim Z, Blaha MJ, Juraschek SP, Keteyian SJ, Brawner CA, Al-Mallah MH.

Circulation. 2015 Dec 22;132(25):e395. doi: 10.1161/CIRCULATIONAHA.115.018758. No abstract available.

PMID:
26700015
30.

Effects of Lowering Glycemic Index of Dietary Carbohydrate on Plasma Uric Acid Levels: The OmniCarb Randomized Clinical Trial.

Juraschek SP, McAdams-Demarco M, Gelber AC, Sacks FM, Appel LJ, White KJ, Miller ER 3rd.

Arthritis Rheumatol. 2016 May;68(5):1281-9. doi: 10.1002/art.39527.

31.

The Gamma Gap and All-Cause Mortality.

Juraschek SP, Moliterno AR, Checkley W, Miller ER 3rd.

PLoS One. 2015 Dec 2;10(12):e0143494. doi: 10.1371/journal.pone.0143494. eCollection 2015.

32.

Response to Comment on Juraschek et al. Cardiorespiratory Fitness and Incident Diabetes: The FIT (Henry Ford ExercIse Testing) Project. Diabetes Care 2015;38:1075-1081.

Juraschek SP, Blaha MJ, Al-Mallah MH.

Diabetes Care. 2015 Nov;38(11):e194-5. doi: 10.2337/dci15-0007. No abstract available.

PMID:
26494817
33.

Stage A Heart Failure Is Not Adequately Recognized in US Adults: Analysis of the National Health and Nutrition Examination Surveys, 2007-2010.

Kovell LC, Juraschek SP, Russell SD.

PLoS One. 2015 Jul 14;10(7):e0132228. doi: 10.1371/journal.pone.0132228. eCollection 2015.

34.

Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation: Results From the Henry Ford Exercise Testing (FIT) Project.

Qureshi WT, Alirhayim Z, Blaha MJ, Juraschek SP, Keteyian SJ, Brawner CA, Al-Mallah MH.

Circulation. 2015 May 26;131(21):1827-34. doi: 10.1161/CIRCULATIONAHA.114.014833. Epub 2015 Apr 22.

PMID:
25904645
35.

Cardiorespiratory fitness and incident diabetes: the FIT (Henry Ford ExercIse Testing) project.

Juraschek SP, Blaha MJ, Blumenthal RS, Brawner C, Qureshi W, Keteyian SJ, Schairer J, Ehrman JK, Al-Mallah MH.

Diabetes Care. 2015 Jun;38(6):1075-81. doi: 10.2337/dc14-2714. Epub 2015 Mar 12.

PMID:
25765356
36.

Physical fitness and hypertension in a population at risk for cardiovascular disease: the Henry Ford ExercIse Testing (FIT) Project.

Juraschek SP, Blaha MJ, Whelton SP, Blumenthal R, Jones SR, Keteyian SJ, Schairer J, Brawner CA, Al-Mallah MH.

J Am Heart Assoc. 2014 Dec;3(6):e001268. doi: 10.1161/JAHA.114.001268.

37.

Comparative associations of diabetes risk factors with five measures of hyperglycemia.

Poon AK, Juraschek SP, Ballantyne CM, Steffes MW, Selvin E.

BMJ Open Diabetes Res Care. 2014 Apr 8;2(1):e000002. doi: 10.1136/bmjdrc-2013-000002. eCollection 2014.

38.

Relation of resting heart rate to risk for all-cause mortality by gender after considering exercise capacity (the Henry Ford exercise testing project).

Aladin AI, Whelton SP, Al-Mallah MH, Blaha MJ, Keteyian SJ, Juraschek SP, Rubin J, Brawner CA, Michos ED.

Am J Cardiol. 2014 Dec 1;114(11):1701-6. doi: 10.1016/j.amjcard.2014.08.042. Epub 2014 Sep 16.

PMID:
25439450
39.

Gout, urate-lowering therapy, and uric acid levels among adults in the United States.

Juraschek SP, Kovell LC, Miller ER 3rd, Gelber AC.

Arthritis Care Res (Hoboken). 2015 Apr;67(4):588-92. doi: 10.1002/acr.22469.

40.

Plasma lactate and incident hypertension in the atherosclerosis risk in communities study.

Juraschek SP, Bower JK, Selvin E, Subash Shantha GP, Hoogeveen RC, Ballantyne CM, Young JH.

Am J Hypertens. 2015 Feb;28(2):216-24. doi: 10.1093/ajh/hpu117. Epub 2014 Jul 3.

41.

Two authors reply.

Juraschek SP, Selvin E.

Am J Epidemiol. 2014 May 1;179(9):1148-9. doi: 10.1093/aje/kwu057. Epub 2014 Mar 26. No abstract available.

42.

Serum uric acid and the risk of mortality during 23 years follow-up in the Scottish Heart Health Extended Cohort Study.

Juraschek SP, Tunstall-Pedoe H, Woodward M.

Atherosclerosis. 2014 Apr;233(2):623-9. doi: 10.1016/j.atherosclerosis.2014.01.026. Epub 2014 Jan 30.

43.

Temporal relationship between uric acid concentration and risk of diabetes in a community-based study population.

Juraschek SP, McAdams-Demarco M, Miller ER, Gelber AC, Maynard JW, Pankow JS, Young H, Coresh J, Selvin E.

Am J Epidemiol. 2014 Mar 15;179(6):684-91. doi: 10.1093/aje/kwt320. Epub 2014 Jan 12.

44.

Plasma lactate and diabetes risk in 8045 participants of the atherosclerosis risk in communities study.

Juraschek SP, Selvin E, Miller ER, Brancati FL, Young JH.

Ann Epidemiol. 2013 Dec;23(12):791-796.e4. doi: 10.1016/j.annepidem.2013.09.005. Epub 2013 Oct 5.

45.

Acute gout after renal transplantation with notable hypouricemia.

Juraschek SP, Kurano T, Rosen A, Gelber AC.

Am J Med. 2013 Oct;126(10):e5-6. doi: 10.1016/j.amjmed.2013.04.008. Epub 2013 Jul 24. No abstract available.

PMID:
23891284
46.

Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.

Grams ME, Juraschek SP, Selvin E, Foster MC, Inker LA, Eckfeldt JH, Levey AS, Coresh J.

Am J Kidney Dis. 2013 Aug;62(2):253-60. doi: 10.1053/j.ajkd.2013.03.013. Epub 2013 Apr 22.

47.

Novel filtration markers as predictors of all-cause and cardiovascular mortality in US adults.

Foster MC, Inker LA, Levey AS, Selvin E, Eckfeldt J, Juraschek SP, Coresh J; CKD Biomarkers Consortium.

Am J Kidney Dis. 2013 Jul;62(1):42-51. doi: 10.1053/j.ajkd.2013.01.016. Epub 2013 Mar 19.

48.

Dose-response association of uncontrolled blood pressure and cardiovascular disease risk factors with hyperuricemia and gout.

Juraschek SP, Kovell LC, Miller ER, Gelber AC.

PLoS One. 2013;8(2):e56546. doi: 10.1371/journal.pone.0056546. Epub 2013 Feb 27.

49.

Lactate and risk of incident diabetes in a case-cohort of the atherosclerosis risk in communities (ARIC) study.

Juraschek SP, Shantha GP, Chu AY, Miller ER 3rd, Guallar E, Hoogeveen RC, Ballantyne CM, Brancati FL, Schmidt MI, Pankow JS, Young JH.

PLoS One. 2013;8(1):e55113. doi: 10.1371/journal.pone.0055113. Epub 2013 Jan 30.

50.

Within-person variability in kidney measures.

Selvin E, Juraschek SP, Eckfeldt J, Levey AS, Inker LA, Coresh J.

Am J Kidney Dis. 2013 May;61(5):716-22. doi: 10.1053/j.ajkd.2012.11.048. Epub 2013 Jan 20.

Supplemental Content

Loading ...
Support Center